AI assistant
SI-BONE, Inc. — Director's Dealing 2025
May 21, 2025
32647_dirs_2025-05-20_813937f5-98b3-49f8-9b3d-0593ec52ed9c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SI-BONE, Inc. (SIBN)
CIK: 0001459839
Period of Report: 2025-05-16
Reporting Person: FRANCIS LAURA (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-16 | Common Stock | S | 250.00 | $20.008 | Disposed | 506511.00 | Direct |
| 2025-05-16 | Common Stock | S | 2028.00 | $19.6877 | Disposed | 504483.00 | Direct |
| 2025-05-16 | Common Stock | S | 3785.00 | $19.662 | Disposed | 500698.00 | Direct |
| 2025-05-16 | Common Stock | S | 3097.00 | $19.6781 | Disposed | 497601.00 | Direct |
| 2025-05-16 | Common Stock | S | 100.00 | $20.01 | Disposed | 497501.00 | Direct |
| 2025-05-16 | Common Stock | S | 100.00 | $20.01 | Disposed | 497401.00 | Direct |
| 2025-05-16 | Common Stock | S | 2231.00 | $19.6812 | Disposed | 495170.00 | Direct |
| 2025-05-16 | Common Stock | S | 794.00 | $19.4801 | Disposed | 496399.00 | Direct |
| 2025-05-19 | Common Stock | S | 5412.00 | $19.487 | Disposed | 490987.00 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 302958.00 | Indirect |
Footnotes
F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F10: Includes 418,615 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F11: Shares held by The David & Laura Joint Rev Tr.
F2: This transaction was executed in multiple trades at prices ranging from $20.00 USD to $20.01 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: This transaction was executed in multiple trades at prices ranging from $19.01 USD to $20.005 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: This transaction was executed in multiple trades at prices ranging from $19.00 USD to $19.96 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: This transaction was executed in multiple trades at prices ranging from $19.01 USD to $20.00 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6: This transaction was executed in multiple trades at prices ranging from $18.98 USD to $19.955 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
F8: This transaction was executed in multiple trades at prices ranging from $19.26 USD to $19.64 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9: Includes 2,023 shares acquired under the SI-BONE, Inc. 2018 Employee Stock Purchase Plan on May 15, 2025.